AMENDMENT NO. 2 TO CREDIT AGREEMENTCredit Agreement • November 9th, 2012 • American Renal Holdings Inc. • Services-misc health & allied services, nec • New York
This AMENDMENT No. 2 dated as of August 27, 2012 (this “Amendment”), is entered into among AMERICAN RENAL HOLDINGS INTERMEDIATE COMPANY, LLC, a Delaware limited liability company (“Holdings”), AMERICAN RENAL HOLDINGS INC., a Delaware corporation (the “Borrower”), the Subsidiary Guarantors party hereto and BANK OF AMERICA, N.A., in its capacity as administrative agent for the Lenders (as hereinafter defined) (in such capacity, the “Administrative Agent”), and amends the Credit Agreement dated as of May 7, 2010 (as amended to the date hereof and as the same may be further amended, supplemented or otherwise modified from time to time, the “Credit Agreement”) entered into among Holdings, the Borrower, the institutions from time to time party thereto as Lenders (the “Lenders”), the Administrative Agent, and the other agents and arrangers party thereto. Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to them in the Credit Agreement.
EMPLOYMENT AGREEMENTEmployment Agreement • October 14th, 2011 • American Renal Holdings Inc. • Services-misc health & allied services, nec • Massachusetts
This EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of October 13, 2011 (the “Effective Date”), among American Renal Management LLC, a Delaware limited liability company (the “Company”), American Renal Holdings Inc., a Delaware corporation (“ARH”), and Jonathan Wilcox, a resident of the Commonwealth of Massachusetts (the “Executive”).
FIRST AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • May 13th, 2011 • American Renal Holdings Inc. • Services-misc health & allied services, nec • Massachusetts
This First Amendment to Employment Agreement (the “Amendment”), is made and entered into this 21st day of April, 2011, by and among American Renal Management, LLC, a Delaware limited liability company (the “Company”), American Renal Holdings, Inc., a Delaware corporation (“ARH”), and John M. McDonough (“Executive”).
